Page 170 - Read Online

Zhang et al. Hepatoma Res 2019;5:14 I http://dx.doi.org/10.20517/2394-5079.2018.117 Page 7 of 9

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declare that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of hepatocellular carcinoma incidence in the United States
forecast through 2030. J Clin Oncol 2016;34:1787-94.
2. Xu Y, Bu X, Dai C, Shang C. High serum microRNA-122 level is independently associated with higher overall survival rate in
hepatocellular carcinoma patients. Tumor Biol 2015;36:4773-6.
3. Hamid AS, Tesfamariam IG, Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries:
geographical distribution, mechanism of action and prevention. Oncol Lett 2013;5:1087-92.
4. Mak LY, Cruz-Ramon V, Chinchilla-Lopez P, Torres HA, LoConte NK, et al. Global epidemiology, prevention, and management of
hepatocellular carcinoma. Am Soc Clin Oncol Educ Book 2018;38:262-79.
5. Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol 2017;72:626-35.
6. Juarez-Hernandez E, Motola-Kuba D, Chavez-Tapia NC, Uribe M, Barbero Becerra V. Biomarkers in hepatocellular carcinoma: an
overview. Expert Rev Gastroenterol Hepatol 2017;11:549-58.
7. Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular
carcinoma. J Hepatol 2012;56:1371-83.
8. Manini MA, Sangiovanni A, Fornari F, Piscaglia F, Biolato M, et al. Clinical and economical impact of 2010 AASLD guidelines for
the diagnosis of hepatocellular carcinoma. J Hepatol 2014;60:995-1001.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Nati Acadof Sci U S A 2008;105:10513-8.
10. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, et al. A serum circulating miRNA diagnostic test to identify asymptomatic
high-risk individuals with early stage lung cancer. EMBO Mol Med 2011;3:495-503.
11. Ji J, Zhao L, Budhu A, Forgues M, Jia HL, et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular
carcinoma. J Hepatol 2010;52:690-7.
12. Zhang J, Yang Y, Yang T, Liu Y, Li A, et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis,
suppresses cell proliferation and tumourigenicity. Br J Cancer 2010;103:1215-20.
13. Ji J, Shi J, Budhu A, Yu Z, Forgues M, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med
2009;361:1437-47.
14. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of
hepatocellular carcinoma. Hepatology 2010;51:836-45.
15. Li D, Liu X, Lin L, Hou J, Li N, et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinoma. J Biol Chem 2011;286:36677-85.
16. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012;61:278-89.
17. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, et al. The microRNA miR-139 suppresses metastasis and progression of
hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011;140:322-31.
18. Jia YS, Liu HL, Zhuang QS, Xu SQ, Yang ZH, et al. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is
regulated by microRNA-145. Oncol Rep 2012;27:1865-72.
19. Wang C, Song B, Song W, Liu J, Sun A, et al. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1alpha in
hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. J Gastroenterol Hepatol 2011;26:1630-7.
20. Li QJ, Zhou L, Yang F, Wang GX, Zheng H, et al. MicroRNA-10b promotes migration and invasion through CADM1 in human
hepatocellular carcinoma cells. Tumor Biol 2012;33:1455-65.